Eulerpool Terminal
The edge that pays for itself.
Current Immix Biopharma forecasts and price targets in August 2026
Ø Analyst Price Targets
12.24 USD
-10.40 %
Median
12.24 USD
-10.40 %
Max
12.60 USD
Min
12.12 USD
Last Price
13.66 USD
Buy
6
Hold
1
Sell
0
The average target price for Immix Biopharma is 12.24 USD. (-10.40 % below the current price)
The median price target of Immix Biopharma is 12.24 USD.
Stock analysts from many renowned investment banks are closely examining the Immix Biopharma stock. They conclude their professional Immix Biopharma stock analyses with a clear recommendation for the Immix Biopharma stock. The forecasts and price targets of professional analysts can be a good indicator of how a stock will perform in the next quarter.
| Buy | Hold | Sell | Ø Analyst Price Targets | |
|---|---|---|---|---|
| 2026-02-01 | 6 | 1 | 0 | 12.24 USD |
| 2026-01-01 | 6 | 1 | 0 | 12.24 USD |
| 2025-12-01 | 6 | 1 | 0 | 12.24 USD |
| 2025-12-01 | 6 | 1 | 0 | 8.16 USD |
| 2025-11-01 | 6 | 1 | 0 | 8.16 USD |
| 2025-11-01 | 6 | 1 | 0 | 8.16 USD |
Immix Biopharma Stock Forecast 2026: Revenue & Earnings Estimates
Analysts expect the following revenue and earnings for Immix Biopharma in the coming fiscal years:
| Fiscal year | Revenue | Net Income | Earnings per share |
|---|---|---|---|
| 2027e | 15.00 M USD | -47.00 M USD | -1.23 USD |
| 2028e | 178.00 M USD | -19.00 M USD | -0.50 USD |
| 2029e | 313.00 M USD | 14.00 M USD | 0.37 USD |